[
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_14",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_14",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_14",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_15",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_15",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_16",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_17",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 164
    }
]